Phase I study of the HSP90 inhibitor AUY922 in combination with capecitabine as treatment for patients with advanced solid tumors

被引：0
|
作者：
Bendell, Johanna C.
Hart, Lowell L.
Pant, Shubham
Infante, Jeffrey R.
Jones, Suzanne Fields
Mohyuddin, Adil
Murphy, Patrick
Patton, Jeffrey
Penley, William Charles
Thompson, Dana Shelton
Burris, Howard A.
机构：
[1] PLLC, Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[2] Florida Canc Specialists SCRI, Ft Myers, FL USA
[3] Stephenson Canc Ctr SCRI, Oklahoma City, OK USA
[4] Sarah Cannon Res Inst & Tennessee Oncol, Nashville, TN USA
[5] Sarah Cannon Res Inst, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.475
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
475
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Anticancer activity of Hsp90 inhibitor AUY922 in nasopharyngeal carcinoma and non-small cell lung cancer cells
    Cho, William C.
    Wong, Chi F.
    CANCER RESEARCH, 2023, 83 (07)
  • [32] A Phase II Trial of AUY922, a Heat Shock Protein 90 (HSP90) Inhibitor, in ALK-Positive Lung Cancer Patients Previously Treated with ALK Inhibitors
    Gainor, Justin F.
    Marcoux, J. P.
    Rabin, Michael
    Gandhi, Leena
    Costa, Daniel B.
    Logan, Jennifer
    Jackman, David M.
    Shaw, Alice
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S649 - S649
  • [33] Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer
    Felip, Enriqueta
    Barlesi, Fabrice
    Besse, Benjamin
    Chu, Quincy
    Gandhi, Leena
    Kim, Sang-We
    Carcereny, Enric
    Sequist, Lecia V.
    Brunsvig, Paal
    Chouaid, Christos
    Smit, Egbert F.
    Groen, Harry J. M.
    Kim, Dong-Wan
    Park, Keunchil
    Avsar, Emin
    Szpakowski, Sebastian
    Akimov, Mikhail
    Garon, Edward B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : 576 - 584
  • [34] Pharmakokinetic/phamacodynamic relationship of the HSP90 inhibitor NVP-AUY922 in human xenografts and patients in a clinical Phase I trial
    Jensen, Michael
    Ide, Susan
    Brueggen, Josef
    Schoepfer, Joseph
    Wang, Xiaofeng
    Quadt, Cornelia
    Garcia-Echeverria, Carlos
    CANCER RESEARCH, 2009, 69
  • [35] Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors
    Do, Khanh T.
    O'Sullivan Coyne, Geraldine
    Hays, John L.
    Supko, Jeffrey G.
    Liu, Stephen V.
    Beebe, Kristin
    Neckers, Len
    Trepel, Jane B.
    Lee, Min-Jung
    Smyth, Tomoko
    Gannon, Courtney
    Hedglin, Jennifer
    Muzikansky, Alona
    Campos, Susana
    Lyons, John
    Ivy, Percy
    Doroshow, James H.
    Chen, Alice P.
    Shapiro, Geoffrey I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (06) : 815 - 827
  • [36] Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors
    Khanh T. Do
    Geraldine O’Sullivan Coyne
    John L. Hays
    Jeffrey G. Supko
    Stephen V. Liu
    Kristin Beebe
    Len Neckers
    Jane B. Trepel
    Min-Jung Lee
    Tomoko Smyth
    Courtney Gannon
    Jennifer Hedglin
    Alona Muzikansky
    Susana Campos
    John Lyons
    Percy Ivy
    James H. Doroshow
    Alice P. Chen
    Geoffrey I. Shapiro
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 815 - 827
  • [37] Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells
    Zitzmann, Kathrin
    Ailer, Galina
    Vlotides, George
    Spoettl, Gerald
    Maurer, Julian
    Goeke, Burkhard
    Beuschlein, Felix
    Auernhammer, Christoph J.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (06) : 1824 - 1832
  • [38] RETRACTION: Potent antitumor activity of HSP90 inhibitor AUY922 in adrenocortical carcinoma (Retraction of Vol 35, Pg 8193, 2014)
    Huang, J.
    Sun, C.
    Zhang, T.
    TUMOR BIOLOGY, 2017,
  • [39] HSP90抑制剂AUY922与氟康唑协同抗真菌活性研究
    贾海瑞
    刘珍
    韩磊
    王苗苗
    刘伟
    陕西科技大学学报, 2021, 39 (02) : 50 - 55+66
  • [40] RETRACTED: Potent antitumor activity of HSP90 inhibitor AUY922 in adrenocortical carcinoma (Retracted article. See April, 2017)
    Huang, Junchao
    Sun, Chengchao
    Zhang, Ting
    Pan, Lei
    Wang, Suqing
    He, Qiqiang
    Li, Dejia
    TUMOR BIOLOGY, 2014, 35 (08) : 8193 - 8199
12345